[Statokinesitherapy in the patients presenting with coronary heart disease associated with arterial hypertension]

Insights

Statokinesitherapy with biofeedback improved rehabilitation for coronary heart disease patients with hypertension and brain circulation issues. Patients experienced fewer symptoms like dizziness and improved balance and stability.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Rehabilitation Therapy

Context:

  • Coronary heart disease (CHD) patients often present with arterial hypertension.
  • These patients may also experience dyscirculatory encephalopathy or vertebrobasilar insufficiency.
  • Cerebral syndromes significantly impact patient quality of life and recovery.

Purpose:

  • To evaluate the efficacy of statokinesitherapy with biofeedback in combined rehabilitative treatment.
  • To assess the impact on clinical symptoms of cerebral syndromes in CHD patients.
  • To determine the effect on objective measures of postural stability.

Summary:

  • Statokinesitherapy with biofeedback was integrated into the rehabilitation of patients with coronary heart disease, arterial hypertension, and cerebral symptoms.
  • The treatment led to a significant reduction in the severity of clinical symptoms, including decreased dizziness and improved gait.
  • Patients demonstrated enhanced coordination, equilibrium, and postural stability, as evidenced by stabilometry.

Impact:

  • Reduced clinical symptoms of cerebral syndromes in patients with cardiovascular and neurological comorbidities.
  • Improved objective measures of postural control and stability.
  • Enhanced functional recovery and quality of life for patients undergoing cardiac rehabilitation.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522